KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY;INTELLIGENT SYNTHETIC BIOLOGY CENTER
发明人:
Won Il Jeong,Sun Chang Kim,Ju Yeon Jung,Wan Taek Im
申请号：
US15058609
公开号：
US20160256477A1
申请日:
2016.03.02
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to a pharmaceutical composition, a health functional food, and a feed composition for the prevention, improvement, or treatment of non-alcoholic liver disease or insulin resistance comprising ginsenoside F2. The pharmaceutical composition according to the present invention comprising ginsenoside F2 can inhibit the adipogenesis and lipid accumulation in the liver, improve insulin sensitivity, inhibit the expression of inflammatory cytokines such as TNF-α, IL-β, and IL-6 in the Kupffer cell, inhibit the expression of endocannabinoid synthase, thus capable of effectively preventing or treating non-alcoholic liver disease or insulin resistance.
